M&A Narrative Stress Test
EYQA® — Narrative Defensibility Platform

M&A Narrative Stress-Test

For Deal Teams, Corporate Development, and Integration Leaders

One of EYQA®'s 27 role-specific Narrative Stress-Tests — one standard of rigor, calibrated to your context.

In 5 minutes, this tool shows you where your M&A narrative would fracture under antitrust review, activist opposition, or shareholder litigation — before the deal timeline exposes it.

Where this applies

A sample of the 9 narrative types this assessment covers:

Deal Rationale Narrative (Investor-Facing) — M&A/Corporate Development Leads, CFOs
Regulatory / Antitrust Filing Narrative — Board & Audit Committee Members
Deal Rationale Narrative (Employee-Facing) — Integration Leads
Synergy & Value Creation Case — Deal Team Members
Cultural Integration Narrative — Integration Leads

+ 4 more, including a custom option — choose yours when you start →

1
Six-question M&A readiness assessment
Covers Synergy Evidence, Rationale Coherence, Stakeholder Perspective, Risk Disclosure, Stage Calibration, and Milestone Commitment.
2
Dimension-specific governance score
See exactly where your M&A narrative is exposed — not as a general impression but against defined deal-scrutiny criteria.
3
Path to expert governance scrutiny review
Submit your actual narrative for human-led review. 48-hour turnaround. Confidential.

Free access  ·  No credit card required  ·  Takes 5 minutes

Already using EYQA tools? Sign in with your existing account.

EYQA® Narrative Defensibility Platform  ·  What Happens During an EYQA Narrative Stress-Test  · 

M&A Narrative Stress-Test

For Deal Teams, Corporate Development, and Integration Leaders

This tool identifies where strong-sounding deal narratives collapse when reinterpreted by hostile or skeptical actors.

Stress-test your M&A narrative against antitrust, activist, and shareholder-litigation scrutiny before the deal timeline exposes it.

Get Your Narrative Defensibility Score
Benchmark your M&A narrative against deal-scrutiny and governance standards.

Select Your M&A Narrative Type

Choose the deal narrative you're preparing for board, regulatory, or public scrutiny

Apply Hostile Interpretation Lens (Optional)

Test your narrative's defensibility through the eyes of parties who scrutinize M&A decisions:

Regulatory Review: How would antitrust or sector regulators interpret this narrative?

Before You Begin

You selected: [M&A Narrative Type]

Think of one specific M&A narrative that your team currently uses with the board, regulators, shareholders, or other stakeholders.

Examples may include:

  • How you describe the deal rationale to investors
  • How you present synergy projections to the board
  • How you frame the regulatory case in an antitrust filing
  • How you communicate the deal to employees

Answer all six questions based on that specific narrative as it exists today.

You do not need to upload the narrative to complete this assessment. By "narrative," we mean the specific way your organization currently explains, presents, or communicates the deal. The narrative may be a board deck, an investor presentation, a regulatory filing, a press release, an employee town hall script, or another recurring articulation of the deal story.

What this assessment evaluates

This assessment evaluates the defensibility of the narrative itself — whether its claims, evidence, logic, stakeholder considerations, risk disclosure, and commitments are structured to withstand board, regulatory, and litigation scrutiny.

This is a narrative readiness diagnostic. It is not legal advice, regulatory guidance, or a guarantee of deal approval.

It does not independently verify the underlying deal data, synergy projections, or market assumptions.

The six dimensions assess the defensibility of the narrative itself:

1 Synergy & Value Evidence
2 Strategic Rationale Coherence
3 Multi-Stakeholder Perspective
4 Integration & Regulatory Risk Disclosure
5 Audience & Deal-Stage Calibration
6 Integration Milestone Commitment

These dimensions are designed to assess narrative defensibility across different M&A contexts. They do not replace the detailed requirements of any specific regulatory filing or legal standard.

Test Your M&A Narrative Defensibility

Answer 6 questions to benchmark against deal-scrutiny and governance standards

1

Synergy & Value Evidence

Scrutiny exposure: How vulnerable are synergy and value-creation claims to challenge?

Quantified & Sourced
Synergies quantified with historical precedent and a clear path to realization; dis-synergies disclosed
Directional & Plausible
Synergies directionally plausible but lack detailed sourcing or realization timeline
Asserted Without Proof
Synergy claims are asserted without adequate evidence; high scrutiny exposure
2

Strategic Rationale Coherence

Scrutiny exposure: Does the deal logic hold together, or does it rely on unstated assumptions?

Sound & Testable
Every element of the strategic rationale follows from evidence or explicit assumptions
Mostly Sound
Core rationale holds; some steps require assumptions that would benefit from explicit naming
Logical Gaps
Material steps rely on unstated assumptions that could be reasonably rejected
3

Multi-Stakeholder Perspective

Scrutiny exposure: How would other parties involved in the deal view this narrative?

Balanced Across Stakeholders
Narrative explicitly considers the perspective of employees, customers, and shareholders
Partially Considered
One or two stakeholder groups are addressed, but others are largely overlooked
Single-Stakeholder Focus
Narrative is focused almost entirely on one stakeholder group with no acknowledgment of others
4

Integration & Regulatory Risk Disclosure

Scrutiny exposure: Are integration challenges and regulatory hurdles openly acknowledged?

Risks Fully Disclosed
Integration challenges and regulatory risks are explicitly named with mitigation thinking
Risks Partially Addressed
Some integration or regulatory risks acknowledged; others glossed over
Risk-Free Presentation
Narrative presents a seamless integration path and no regulatory hurdles
5

Audience & Deal-Stage Calibration

Is this narrative calibrated to the specific audience and the specific stage of the deal?

Precisely Calibrated
Depth, framing, and evidence are tuned to the specific audience (board, regulator, employee) and stage (announcement, review, integration)
Partially Calibrated
Reasonably fits most audiences but not specifically tuned to the receiving party or deal stage
One-Size-Fits-All
Same narrative delivered regardless of who is in the room or where in the process the conversation is
6

Integration Milestone Commitment

Does this narrative give stakeholders a clear, checkable basis for tracking the deal's success — or does it leave integration commitments vague?

Clear & Checkable
Specific integration milestones with dates and owners, allowing stakeholders to track progress
Directional
Commitments are directional rather than specific; some milestones lack dates or owners
Vague Commitments
Integration commitments are vague or absent; no clear way to track success against the narrative

M&A Narrative for: [M&A Narrative Type]
Deal-Scrutiny and Governance Defensibility Results

Your M&A Narrative Defensibility Results
0/100
-
Synergy & Value Evidence
Evidence
-
Strategic Rationale
Logic
-
Stakeholder Perspective
Perspective
-
Risk Disclosure
Risk Awareness
-
Audience & Stage
Contextual Fit
-
Integration Milestones
Actionability

From Defensibility to Action

Your score indicates how the narrative performs across the six dimensions assessed. Use this as a diagnostic to identify areas for further validation or improvement.

0–50 — At Risk
Immediate deal-team attention required. Significant defensibility gaps that would raise serious concerns under scrutiny. Prioritize a rapid internal review of your weakest dimensions before any external filing or board presentation.
51–70 — Developing
Needs deal-team attention. The narrative has a foundation but contains areas that may require strengthening before deeper regulatory or board scrutiny. Focus on the lowest-scoring dimensions.
71–85 — Strong
Board-ready defensibility. The narrative demonstrates several strong defensibility characteristics, with targeted improvement opportunities remaining. Fine-tune remaining gaps.
86–100 — Elite
Regulator- and litigation-grade defensibility. Exceptional narrative strength. Consider independent validation to confirm, then use as a benchmark for future deals.

Based on your defensibility score, choose your next step:

Get Deal-Scrutiny Narrative Review

Beyond this automated score, get a comprehensive scrutiny simulation from EYQA M&A narrative experts.
Submit your actual M&A narrative for human-led defensibility exposure analysis.

All submissions are confidential and analyzed by EYQA M&A narrative experts only.

AI-Assisted Preview Prompt

A calibrated, structured review prompt you run in your own LLM (Claude, ChatGPT, Gemini, etc.). Not an analysis performed by EYQA — see disclosure before use.

Ready for deal-scrutiny and governance strategy discussion?

45-minute deal-scrutiny and governance strategy call with EYQA experts

Professional Use & Framework Intent

EYQA® M&A Narrative Stress-Tests are designed as professional reflection and scrutiny tools to support deal teams and corporate development leaders in high-stakes transaction contexts.

Professional Use

This assessment is intended for personal or internal professional use to evaluate M&A narrative defensibility under regulatory and board scrutiny. It does not constitute legal advice, investment advice, or regulatory guidance.

No Automated Scoring or AI Judgment

This assessment applies predefined professional M&A evaluation frameworks. No AI-based scoring, investment recommendations, or decision-making is performed.

Responsibility for Deal Decisions

Insights generated are diagnostic in nature. Deal teams and corporate development leaders remain fully responsible for due diligence, regulatory compliance, and how assessment results are interpreted and applied.

Intellectual Property

All frameworks, structures, assessment designs, and M&A evaluation methodologies are the intellectual property of EYQA®. Use does not transfer ownership or licensing rights.

No Redistribution

This M&A narrative assessment tool and its underlying framework may not be republished, resold, or redistributed as a standalone product, service, or asset.

Access & Availability Rights

EYQA® reserves all rights to modify, restrict, or terminate free access to this M&A narrative stress-test tool at any time, with or without notice.

No Guarantee of Continued Availability

Access to this M&A narrative assessment tool is provided on an "as available" basis. EYQA® makes no guarantees regarding uninterrupted availability, feature continuity, or perpetual free access.

EYQA® reserves the right to update this M&A narrative assessment tool, its frameworks, and these terms of use as professional M&A standards evolve. Continued use constitutes acceptance of updated terms.